PRTN3 and rheumatoid arthritis: Surprisingly, studies in early RA cohorts diagnosed according to the 2010 classification criteria have shown that ACPA might rather be regarded as a marker of better outcomes, as ACPA-positive patients more frequently achieve remission upon induction therapy with high doses of MTX (81).